000 01156 a2200313 4500
005 20250513200919.0
264 0 _c20000208
008 200002s 0 0 eng d
022 _a8756-0437
024 7 _a10.1002/(sici)1098-2388(200001/02)18:1<80::aid-ssu10>3.0.co;2-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTjoa, B A
245 0 0 _aProgress in active specific immunotherapy of prostate cancer.
_h[electronic resource]
260 _bSeminars in surgical oncology
_c
300 _a80-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdjuvants, Immunologic
650 0 4 _aCancer Vaccines
_xtherapeutic use
650 0 4 _aCytokines
_xpharmacology
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_ximmunology
650 0 4 _aVaccines, DNA
_xtherapeutic use
700 1 _aMurphy, G P
773 0 _tSeminars in surgical oncology
_gvol. 18
_gno. 1
_gp. 80-7
856 4 0 _uhttps://doi.org/10.1002/(sici)1098-2388(200001/02)18:1<80::aid-ssu10>3.0.co;2-a
_zAvailable from publisher's website
999 _c10573590
_d10573590